Veracyte Inc
F:12V
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Veracyte Inc
F:12V
|
US |
|
G
|
Genus PLC
F:GBE
|
UK |
|
K
|
Kyocera Corp
OTC:KYOCF
|
JP |
|
Entera Bio Ltd
F:5DT
|
IL |
|
Virgin Money UK PLC
OTC:CYBBF
|
UK |
|
F
|
Ferrexpo PLC
XMUN:FEX
|
CH |
|
Ferrexpo PLC
F:FEX0
|
CH |
|
Ship Healthcare Holdings Inc
F:5EZ
|
JP |
Wall St Price Targets
12V Price Targets Summary
Veracyte Inc
According to Wall Street analysts, the average 1-year price target for 12V is 26.37 EUR with a low forecast of 18.87 EUR and a high forecast of 34.47 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 12V's stock price target?
Price Target
26.37
EUR
According to Wall Street analysts, the average 1-year price target for 12V is 26.37 EUR with a low forecast of 18.87 EUR and a high forecast of 34.47 EUR.
What is the Revenue forecast for Veracyte Inc?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 3 years is 12%.
What is the Gross Profit forecast for Veracyte Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 41%. The projected CAGR for the next 3 years is 15%.
What is the Operating Income forecast for Veracyte Inc?
Projected CAGR
24%
The compound annual growth rate for Operating Income over the next 3 years is 24%.
What is the Pre-Tax Income forecast for Veracyte Inc?
Projected CAGR
34%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 34%.
What is the Net Income forecast for Veracyte Inc?
Projected CAGR
30%
The compound annual growth rate for Net Income over the next 3 years is 30%.
